The 3D Medical Application Center of the U.S. Army customized assistive devices and artificial limbs for 3D printing of veterans
New Targeted Drug For Leukaemia Approved, 35% Of Patients' Cancer Cells Disappear Completely!
The sensational feeling channel in the world -- where there is perception, there is pain and happiness
Cutting-Edge Targeted Drug For Cholangiocarcinoma Significantly Extends Patients' Lives!
New CAR-T Therapy CB-010, Granted Two FDA Designations And Three Patients Are Cancer-Free For Six Months!
Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China
